Guerrero Ramiro 4

What Happened Ramiro Guerrero, a director of MAIA Biotechnology, Inc. (MAIA), received a grant of 26,355 stock options on June 30, 2026. The Form 4 reports the acquisition price as $0.00 for the derivative award. This is an equity compensation grant (award), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-30; Form 4 filed: 2026-07-02.
• Grant: 26,355 stock options; reported acquisition price: $0.00 (derivative instrument).
• Shares owned after transaction: not specified in the provided filing summary.
• Footnote: Options were granted under MAIA’s 2021 Equity Incentive Plan, vest 100% on the grant date and are exercisable beginning as of that date (i.e., immediately vested and exercisable).
• No exercise or sale was reported in this filing.

Context These are stock option awards (a common form of director compensation). Although immediately vested and exercisable per the footnote, this filing does not show any exercise (conversion into shares) or sale of underlying shares. Awards are informative about compensation but do not by themselves indicate the director’s intent to buy or sell stock on the open market.